| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 3e-11 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.26 | 6e-05 |